JAK2 and breast carcinoma: C14orf166 interacts with ninein to block the phosphorylation of ninein catalyzed by GSK-3β [13], suggesting C14orf166 may inhibit ninein, and activate JAK2 to promote breast cancer progression, but this speculation remain to be confirmation.